OptiBiotix to launch SlimBiome Medical in UK market this month

(Sharecast News) - Life sciences business OptiBiotix Health announced the launch of its weight management product 'SlimBiome Medical' to the UK market on Wednesday.The AIM-traded firm said SlimBiome Medical, which is a CE-marked medical device, offered a "healthy, hunger-free" weight management solution designed for use by itself, or as part of a calorie-restricted diet, to reduce hunger and help users achieve sustainable weight loss.Independent clinical studies showed SlimBiome reduced hunger, cravings for sweet and savoury foods, and fat intake.It would be available in boxes of 30 single dose sachets, and for purchase from the company's online store, from 29 April.The board said the commercial launch followed its announcement that SlimBiome was granted medical device status and a CE-mark in November, as well as the appointment of Nutrilinea as a manufacturer in the same month, and three-year distribution agreements for Greece and Cyprus in December and Bulgaria in April.OptiBiotix also reported pre launch sales of SlimBiome Medical to Bridge4 Health - a "unique" health and wellbeing centre based in Leicester.Bridge4 Health would conduct a three-month SlimBiome Medical field trial involving its gym members to support healthy sustained weight loss.The early deals and sales orders so soon after achieving medical device registration reflected the "high level" of interest received in the product from an industry which recognised the value of products with "strong science" and published human studies, the board explained.It added that the online sale of SlimBiome Medical as a final product was another example of OptiBiotix's strategy of building multiple revenue streams from ingredient sales, white label and own label branded consumer products, across multiple sales channels.The channel would provide a new route to market for SlimBiome, allowing the firm to generate immediate revenues while building sales with international and retail partners from SlimBome as an ingredient, medical device, and in white label or branded 'GoFigure' final products.OptiBiotix said it anticipated further commercial agreements for SlimBiome, SlimBiome Medical, and GoFigure products in international markets in the months ahead."SlimBiome Medical is a innovative product transforming the way weight loss is traditionally approached as it delivers a sustainable, science-backed weight control system which offers dieters additional support to sustain and/or maintain weight loss," said managing director of the OptiBiotix prebiotics division Fred Narbel."We are delighted to be able to bring this product to the UK market through our online store which allows us to build early revenues at high margin through direct to consumer sales."